… To identify long-term asthma-related QoL outcomes associated with omalizumab therapy
in patients with moderate-to-severe asthma, we developed a systematic review according to …

… of omalizumab therapy in severe allergic neous injections at a dose determined from the
prescribasthma, … zumab treatment in severe allergic asthma: the South-Eastern 17. Humbert M, …

… omalizumab for moderate-to-severe allergic asthma in the US in 2003 and for severe allergic
asthma … to evaluate the effectiveness of omalizumab add-on therapy under conditions of …

… We retrospectively reviewed data of all severe asthma patients who were treated with
omalizumab … Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled …

… -years of exposure (Unpublished data, Omalizumab Periodic Safety Report [PSUR], Novartis…
severe allergic asthma (SAA) has shown the short- and long-term efficacy of omalizumab by …

… has also been found to decrease the sensitivity to CD antigens of the responsible allergens
after long-term use irrespective of total or specific IgE levels [34]. Apart from IgE.; which is an …

… -severe persistent allergic asthma. The efficacy and safety of omalizumab treatment in allergic
asthma … adult patients with allergic asthma who received omalizumab treatment for at least …

… were included, while events related to the long-term use of maintenance OCS were considered
given their significant cost and HRQOL implication. Rates of OCS-related events derived …

… severe allergic asthma patients registered for omalizumab treatment in Poland from 50 severe
asthma treatment … The efficacy of long-term omalizumab treatment was assessed at strictly …

… Allergic asthma is a long-term disorder of the airways resulting … severe persistent allergic
asthma, omalizumab therapy could be … morbidity or the more severe forms of the disease [21]. …